Immune checkpoint inhibitors and biomarker-driven strategies for managing lung cancer | Dr Keith Kerr at Annual Meeting 2015 - 101271

Spotlight
Video

Immune checkpoint inhibitors and biomarker-driven strategies for managing lung cancer | Dr Keith Kerr at Annual Meeting 2015

EMJ has 458 videos Subscribe Here

Loading........
Description: At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Keith Kerr, BSc, MB, ChB, FRCPath, FRCPE, of the University of Aberdeen, Aberdeen, Scotland, reviews the development of immune checkpoint inhibitors targeting the programmed cell death protein 1 (PD-1) signalling pathway and the identification of predictive biomarkers of response to immunotherapies for the management of patients with lung cancer.

–––

European Medical Journal

Website: http://emjreviews.com/...
Twitter: https://twitter.com/EMJRevi...
Facebook: https://www.facebook.com/em...
Shared By : EMJ
Posted on : 08/28/15
Added : 2 years ago



Recommended

Nothing found.

More From EMJ

Nothing found.